ArticleCase reports in ophthalmology
Cancer-Associated Retinopathy and Optic Neuropathy in a Patient with Lung Adenocarcinoma.
Article in Case reports in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Paraneoplastic vision loss includes a heterogenous group of ocular disorders that occur in the setting of systemic malignancy. The presenting symptoms are variable but typically include vision loss that is painless, subacute in onset, and ultimately bilateral. The underlying mechanism is thought to involve molecular mimicry due to structural homology between ocular and cancer antigens. Very few cases have reported simultaneous retinopathy and optic neuropathy. Case Presentation: Here, we present the case of a 36-year-old female who developed complete vision loss in the right eye, with both retina and optic nerve changes. Extensive investigation revealed a non-mucinous lung adenocarcinoma. Conclusion: Presentations of paraneoplastic vision loss include cancer-associated retinopathy, paraneoplastic optic neuropathy, paraneoplastic vitelliform maculopathy, bilateral diffuse uveal melanocytic proliferation, melanoma-associated retinopathy, and opsoclonus-myoclonus syndrome. We suggest use of the term CARON (cancer-associated retinopathy and optic neuropathy) for cases such as this.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.